Literature DB >> 19430650

Veterinary vaccines against Toxoplasma gondii.

Elisabeth A Innes1, Paul M Bartley, Stephen Maley, Frank Katzer, David Buxton.   

Abstract

Toxoplasma gondii has a very wide intermediate host range and is thought to be able to infect all warm blooded animals. The parasite causes a spectrum of different diseases and clinical symptoms within the intermediate hosts and following infection most animals develop adaptive humoral and cell-mediated immune responses. The development of protective immunity to T. gondii following natural infection in many host species has led researchers to look at vaccination as a strategy to control disease, parasite multiplication and establishment in animal hosts. A range of different veterinary vaccines are required to help control T. gondii infection which include vaccines to prevent congenital toxoplasmosis, reduce or eliminate tissue cysts in meat producing animals and to prevent oocyst shedding in cats. In this paper we will discuss some of the history, challenges and progress in the development of veterinary vaccines against T. gondii.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430650     DOI: 10.1590/s0074-02762009000200018

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  31 in total

1.  AMA1-deficient Toxoplasma gondii parasites transiently colonize mice and trigger an innate immune response that leads to long-lasting protective immunity.

Authors:  Vanessa Lagal; Márcia Dinis; Dominique Cannella; Daniel Bargieri; Virginie Gonzalez; Nicole Andenmatten; Markus Meissner; Isabelle Tardieux
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

2.  Parasites: Kitty carriers.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

3.  Use of chicken embryonated eggs for evaluating the virulence of Toxoplasma gondii.

Authors:  A Setasimy; M Namavari
Journal:  J Parasit Dis       Date:  2015-02-14

Review 4.  Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.

Authors:  Andrew J Neville; Sydney J Zach; Xiaofang Wang; Joshua J Larson; Abigail K Judge; Lisa A Davis; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

5.  Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; evidence of frequent acquired infection.

Authors:  Frank Katzer; Franz Brülisauer; Esther Collantes-Fernández; Paul M Bartley; Alison Burrells; George Gunn; Stephen W Maley; Chris Cousens; Elisabeth A Innes
Journal:  Vet Res       Date:  2011-12-21       Impact factor: 3.683

6.  Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what's next?

Authors:  Bozena Dziadek; Anna Brzostek
Journal:  Bioengineered       Date:  2012-08-15       Impact factor: 3.269

Review 7.  Molecules to modeling: Toxoplasma gondii oocysts at the human-animal-environment interface.

Authors:  Elizabeth VanWormer; Heather Fritz; Karen Shapiro; Jonna A K Mazet; Patricia A Conrad
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-12-04       Impact factor: 2.268

8.  Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.

Authors:  Marcin M Grzybowski; Bożena Dziadek; Justyna M Gatkowska; Katarzyna Dzitko; Henryka Długońska
Journal:  Parasitol Res       Date:  2015-09-04       Impact factor: 2.289

Review 9.  Development of Toxoplasma gondii vaccine: A global challenge.

Authors:  Ramesh Verma; Pardeep Khanna
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

10.  A comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models.

Authors:  Hayam Mohamed Ezz Eldin; Hanan Hussein Kamel; Abeer Fathy Badawy; Lobna Sadek Shash
Journal:  J Parasit Dis       Date:  2013-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.